Rapid Micro Biosystems (RPID) Change in Account Payables (2020 - 2026)

Rapid Micro Biosystems has disclosed Change in Account Payables across 7 years of filings, most recently posting $530000.0 for Q1 2026.

• Change in Account Payables for Q1 2026 came in at $530000.0, up 430.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.0 million (up 38.0% YoY), and the FY2025 annual result was $1.6 million, up 184.7% from the prior year.
• Change in Account Payables came in at $530000.0 for Q1 2026 at Rapid Micro Biosystems, down from $549000.0 in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $1.9 million in Q3 2023 to a low of -$4.1 million in Q1 2023.
• The 5-year median for Change in Account Payables is $205000.0 (2024), against an average of $42411.8.
• Across the five-year window, Change in Account Payables sank 1037.5% in 2022 and jumped 1219.48% in 2024, its largest moves.
• Rapid Micro Biosystems' Change in Account Payables stood at $1.8 million in 2022, then slumped by 173.79% to -$1.3 million in 2023, then soared by 115.79% to $205000.0 in 2024, then jumped by 167.8% to $549000.0 in 2025, then dropped by 3.46% to $530000.0 in 2026.
• The last three Change in Account Payables figures came in at $530000.0 (Q1 2026), $549000.0 (Q4 2025), and $251000.0 (Q3 2025), per Business Quant data.